The Next Big Thing In Biotech: Large-Cap Earnings
Earnings from a slew of large-cap biotech players including Celgene, Biogen and Amgen will be the next big thing biotech, Adam Feuerstein, Sr. Columnist for TheStreet, tells Gregg Greenberg.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
